Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001193125-25-241754·Astria Therapeutics, Inc.
Schedule 13D ownership disclosure
ASTRIA THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 04635X102
Event date: 2025-10-14
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Perceptive Advisors LLCReported CIK 0001224962
Shares: 6,485,420 · Class: 11.5%
- Joseph EdelmanReported CIK 0001164426
Shares: 6,485,420 · Class: 11.5%
- Perceptive Life Sciences Master Fund, Ltd.Reported CIK 0001249675
Shares: 4,873,721 · Class: 8.6%
- Perceptive Xontogeny Venture Fund, L.P.Reported CIK 0001757940
Shares: 1,611,699 · Class: 2.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-241754
- Form type
- SCHEDULE 13D/A
- Filer
- Astria Therapeutics, Inc.
- CIK
- CIK 1454789
- Filed
- Oct 16, 2025
- Reporting period
- Oct 14, 2025
- Description
- Schedule 13D beneficial ownership